BioMarin Pharmaceutical Inc. buy melinda
Start price
28.03.18
/
50%
€71.88
Target price
01.05.18
€77.57
Performance (%)
8.09%
End price
01.05.18
€77.70
Summary
This prediction ended on 01.05.18 with a price of €77.70. The BUY prediction by melinda finished with a performance of 8.09%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 1.252% | 1.252% | -5.258% | 12.009% |
| iShares Core DAX® | 0.238% | -2.265% | 13.679% | 14.917% |
| iShares Nasdaq 100 | -0.304% | 5.808% | 34.538% | 52.796% |
| iShares Nikkei 225® | 2.271% | 1.577% | 9.436% | 5.432% |
| iShares S&P 500 | -0.296% | 4.447% | 28.577% | 47.257% |
Comments by melinda for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
SektorPharmazeutika
Die Europäische Arzneimittelagentur (EMA) akzeptiert den Antrag von BioMarin auf die Pivalvias AAM zur Behandlung von Phenylketonurie (PKU)
FDA PDUFA-Aktionstag für Pegvaliase ist der 25. Mai 2018
Stopped prediction by melinda for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€62.00
29.09.19
29.09.19
€80.00
04.11.21
04.11.21
16.06%
05.11.21
05.11.21
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€88.42
07.09.18
07.09.18
€91.10
20.09.18
20.09.18
3.04%
20.09.18
20.09.18
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.61
08.11.17
08.11.17
€85.69
03.01.18
03.01.18
8.56%
03.01.18
03.01.18
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€83.83
08.11.17
08.11.17
€95.00
03.01.18
03.01.18
8.56%
03.01.18
03.01.18
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€77.73
27.01.17
27.01.17
€85.69
01.03.17
01.03.17
10.23%
01.03.17
01.03.17
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€82.62
10.07.16
10.07.16
€90.20
01.08.16
01.08.16
10.03%
01.08.16
01.08.16